At the end of the first quarter of 2019, Hudson Bay Capital Management held the most valuable stake in Liberty Expedia Holdings, Inc. (NASDAQ:LEXEA), an online travel company.
Keep Reading →
June 11 - Hedge Funds, News
"By the end of the First Quarter, equity markets had mostly bounced back from Q4 2018’s sharp decline. The dovish shift in Fed policy – which over the last six months went...
Keep Reading →
May 23 - Hedge Funds, Lists, News
AQR Capital Management (AQR) has established an office in Frankfurt, Germany.
Keep Reading →
April 12 - Hedge Funds, Insider Trading
BOSTON (Reuters) - Activist hedge fund Starboard Value LP said on Friday it will no longer urge shareholders to oppose Bristol-Myers Squibb Co’s plans to buy Celgene Corp, even...
Keep Reading →
March 29 - Hedge Funds, Insider Trading
A Texas judge Tuesday dismissed a bondholder lawsuit against Neiman Marcus Group over the company’s transfer of its MyTheresa e-commerce business beyond the reach of bondholders...
Keep Reading →
March 19 - Hedge Funds, Insider Trading
Warren Buffett is possibly the financial world's most vocal critic of hedge funds.
Keep Reading →
March 12 - Hedge Funds, Insider Trading
After seeing a "significant risk" of a recession only a month ago, the manager of the world's largest hedge fund has lowered his odds of an economic downturn, now that the Federal...
Keep Reading →
February 28 - Hedge Funds, Insider Trading
NEW YORK (Reuters) - Billionaire investor Steve Cohen’s Point72 Ventures has invested in a U.S.
Keep Reading →
February 20 - Hedge Funds, Insider Trading
Healthcare sector has proven itself to be one of the most resilient sectors of the US economy.
Keep Reading →
March 11 - Hedge Funds, News
Etsy’s stock price jumped as much as 24% in midday trading on Wednesday, and has now more than doubled from a year ago, thanks to Silverman’s turnaround strategy that got ...
Keep Reading →
February 28 - Market Movers, News
The biotech sector is well known for its M&A activity, but billionaire fund managers don’t seem to be attracted by the frenzy.
Keep Reading →
February 5 - Hedge Funds, News
Mott Capital Management is a thematic growth fund that was founded in 2014 by Michael J. Kramer. Mr.
Keep Reading →
January 17 - Hedge Fund Investor Letters, Hedge Funds, News
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at...
Keep Reading →
February 23 - News, Stock Analysis
Five months ago, Delinia was just a fledgling autoimmune startup with just four full-time staff.
Keep Reading →
January 27 - News, Stock Analysis
Celgene Corporation (NASDAQ:CELG) announced today its 2017 GAAP earnings per share of $5.85–$6.21.
Keep Reading →
January 25 - News, Stock Analysis
Earlier this year, we looked at a privately held biotech called Jounce Therapeutics.
Keep Reading →
January 3 - News, Stock Analysis
Julian Robertson is one of the most scrutinized investors on Wall Street, even though he closed his Tiger Management fund back in 2000.
Keep Reading →
December 16 - Hedge Funds, News, Tech
Celgene Corporation (NASDAQ:CELG) has recently unveiled the results from the randomized, Phase 2 tnAcity clinical trial evaluating Abraxane for injectable suspension as part of...
Keep Reading →
December 8 - News, Stock Analysis
bluebird bio Inc (NASDAQ:BLUE) is up sharply pre market on Thursday, as the company put out fresh interim data from a phase I study of its multiple myeloma (MM) asset, bb2121.
Keep Reading →
December 1 - News, Stock Analysis
GlobeImmune Inc (OTCMKTS:GBIM) shareholders did not have a good week last week.
Keep Reading →
November 21 - News, Stock Analysis
Financial metrics such as P/E ratios, price to cash flow ratios, PEG ratios, price to sales ratios, price to book value, and many others, should be thought of as tools in the ...
Keep Reading →
November 4 - News, Stock Analysis
Markets are bearish on Wednesday as investors await minutes from the Federal Open Market Committee’s September meeting, which would likely give an idea about policymakers’ ...
Keep Reading →
October 12 - Market Movers, News
It was back in April when the Chief Medical Officer of pharma giant Celgene Corporation (NASDAQ:CELG), Dr. Jerome B. Zeldis joined the board of MetaStat Inc. (OTCMKTS:MTST).
Keep Reading →
October 10 - News, Stock Analysis
Extensive research shows that corporate insiders tend to make more profit-generating trades than the average non-insider, which serves as the primary reason Insider Monkey, retail...
Keep Reading →
September 27 - Insider Trading, News
Markets inched up before the bell on Monday amid news that recent polls indicated that the British voters are now more inclined towards staying in the EU.
Keep Reading →
June 20 - Market Movers, News
All three index futures are in the green as traders await the Fed's upcoming interest rate decision later today. If rates remain low, the U.S.
Keep Reading →
June 15 - Market Movers, News
Among some 800 hedge funds we track at Insider Monkey, we seldom come across funds that specialize in investing in a particular sector or have a penchant for investing in companies...
Keep Reading →
May 16 - Hedge Funds, News
Birchview Capital is a Vermont-based biosciences-focused long/short equity hedge fund founded by Dr. Matthew Strobeck in 2014. Dr. Strobeck holds a Ph.D.
Keep Reading →
May 15 - Hedge Funds, News
It's the middle of earnings season and many investors are hungrily dissecting earnings reports and management commentary to get a better view on earnings outlooks for the future...
Keep Reading →
April 28 - Market Movers, News
Markets were tumbling on Monday, with all major U.S. stock indexes down substantially, driven by a selloff in tech stocks and a decline in oil prices.
Keep Reading →
February 8 - Market Movers, News
The insider trading activity was very torpid in the past two holiday-shortened trading weeks, but several companies still witnessed heavy insider selling.
Keep Reading →
January 4 - Insider Trading, News
Wall Street is rising on Wednesday with all three major indexes trading in the green and shares of Freeport-McMoRan Inc (NYSE:FCX), ArcelorMittal SA (ADR) (NYSE:MT), Celgene Corporation...
Keep Reading →
December 23 - Market Movers, News
Financial advisors employ considerable resources to identify the best stocks that they could provide advice on to their customers.
Keep Reading →
December 10 - News
Mariner Investment Group is a New York-based investment advisory firm founded by William Michaelcheck in 1992.
Keep Reading →
November 13 - Hedge Fund Analysis, Hedge Funds, News
Massachusetts-based Arrowstreet Capital recently has issued its latest 13F filing with the Securities and Exchange Commission for the reporting quarter ended September 30.
Keep Reading →
November 12 - Hedge Funds, News
Sivik Global Healthcare is a Greenwich, Connecticut-based healthcare-focused hedge fund founded by Krishen Sud in 2006.
Keep Reading →
November 9 - Hedge Fund Analysis, Hedge Funds, News
Beech Hill Advisors is a New York-based registered investment advisor founded by Paul Cantor and Joseph Weiss in 1987. Mr.
Keep Reading →
November 6 - Hedge Funds, News
Three notable companies were given upgrades by analysts this morning, mostly due to recent weakness in the price of their shares (but then, few stocks have been able to escape...
Keep Reading →
October 1 - Hedge Funds, News
Silver Arrow Partners, L.P, a New York-based fund, reported returns of 1.04% for the second quarter of 2015 along with year-to-date returns of 0.75% in its recently released ...
Keep Reading →
July 23 - Hedge Funds, News
The shares of both Receptos Inc (NASDAQ:RCPT) and Celgene Corporation (NASDAQ:CELG) are trading 10% higher after the two pharmaceutical companies entered into a definitive merger...
Keep Reading →
July 15 - Hedge Funds, News
Juno Therapeutics Inc (NASDAQ:JUNO) jumped to a $67.22 per share pre-market high today, or 45.18% from the stock’s closing price yesterday, as the company announced that it ...
Keep Reading →
June 30 - Hedge Funds, News
Matthew Hulsizer's Peak6 Investments, L.P. has filed its 13F with the SEC for the reporting period of March 31.
Keep Reading →
May 15 - Hedge Funds, News
Matthew Tewksbury's Stevens Capital Management has disclosed its equity holdings in a 13F filing with the SEC for the reporting period of March 31.
Keep Reading →
May 11 - Hedge Funds, News
Dr. Matthew Strobeck's Birchview Capital has recently disclosed its equity holdings in a 13F filing with the SEC.
Keep Reading →
April 29 - Hedge Funds, News
Hedge fund manager Kyle Bass has expanded the number of drug companies whose patents he has targeted to five.
Keep Reading →
April 23 - Hedge Funds
In the last couple of years, biotechnology industry has been a hot topic and investors have been watching closely as the industry gained on average 40% in the last three years...
Keep Reading →
March 23 - Hedge Funds, News
With the high volatility prevalent in the biotechnology sector, investors have a hard time picking the right stocks to invest in.
Keep Reading →
February 23 - Hedge Funds, News
The stage is set for the 56th American Society of Hematology (ASH) conference from Dec 6-9 at San Francisco.
Keep Reading →
December 7 - News
Biogen Idec Inc (NASDAQ:BIIB) and Gilead Sciences, Inc.
Keep Reading →
September 6 - News, Stock Analysis